What supplements help with perimenopause cravings?

Several supplement ingredients have human clinical evidence relevant to the specific craving mechanisms that perimenopause disrupts. The important caveat is that no supplement has been validated in a dedicated perimenopause cravings trial, and most evidence comes from general adult or general female populations with overlapping but not identical characteristics. This article maps the options to the mechanisms they address, with honest evidence for each.

Why Perimenopause Cravings Are Different

Standard hunger responds to caloric deficit. Perimenopause cravings are driven by four overlapping disruptions: reduced leptin sensitivity making meals less satisfying, lower serotonin availability creating reward-seeking food behavior, insulin resistance generating reactive hunger after blood sugar drops, and poor sleep from night sweats raising ghrelin independently of calories. An approach that only addresses one of these will miss the others.

The Supplements with the Most Relevant Evidence

Saffron Extract (Satiereal): Serotonin-Pathway Cravings

Best for: mood-linked cravings, stress-driven snacking, carbohydrate-seeking behavior driven by serotonin dysregulation.

Evidence: in a randomized, double-blind, placebo-controlled trial of 60 mildly overweight women over 8 weeks, saffron extract significantly reduced snacking frequency and produced a satiating effect compared to placebo.¹ The proposed mechanism is serotonin pathway support, directly relevant to the serotonin component of perimenopause cravings.

Evidence classification: one RCT in a general mildly overweight female population; not perimenopause-specific. Single trial; not replicated. Not a treatment for clinical eating disorders.

Beta-Glucan and Soluble Fiber: Blood Sugar and Physical Satiety

Best for: reactive hunger driven by blood sugar drops after meals, physical hunger returning too quickly after eating.

Evidence: the NIH ODS notes that beta-glucans may increase satiety, delay GI transit, and slow glucose absorption.² These effects address the blood sugar fluctuation component of perimenopause reactive hunger. This is a mechanistic support claim based on consistent physiological data, not a weight-loss or appetite-suppression trial.

Glucomannan has been studied directly for appetite in a placebo-controlled trial and showed no significant difference in hunger or fullness vs. placebo over 8 weeks, though it was well tolerated. It is more appropriate for regularity support than direct appetite suppression.

Dihydroberberine: Metabolic and Blood Sugar Support

Best for: insulin resistance-driven reactive hunger, carbohydrate-specific cravings linked to blood sugar instability.

Evidence: dihydroberberine is a more bioavailable form of berberine that achieves higher plasma berberine exposure at lower doses, reducing the GI side effects of standard berberine. Its mechanism targets AMPK activation and glucose metabolism, directly relevant to the insulin resistance component of perimenopause appetite dysregulation.

Evidence classification: ingredient-level metabolic evidence. No dedicated perimenopause cravings RCT. Safety note: discuss with your clinician if you take glucose-lowering medications.

Probiotics Supporting GLP-1 Secretion: Gut-Metabolic Appetite Support

Best for: appetite management through the gut hormone pathway, food noise related to inadequate satiety signaling.

Evidence: specific probiotic strains and botanical ingredients that support natural GLP-1 secretion from intestinal L-cells address the satiety hormone pathway at the gut level. GLP-1 is the gut-derived hormone involved in satiety signaling, gastric emptying, and insulin response. Ingredient-level clinical research on GLP-1 secretion support (such as Eriomin lemon extract) provides a nutritional mechanism for this pathway.

B420 (Bifidobacterium animalis subsp. lactis 420) has 6-month RCT evidence showing reduced energy intake in overweight adults alongside body fat management effects.³ Ingredient-level evidence in general overweight adults; not perimenopause-specific; energy intake reduction is an appetite-adjacent finding, not a primary appetite endpoint.

Evidence classification: ingredient-level; no perimenopause-specific appetite trial.

Terms to Know!

• GLP-1 (glucagon-like peptide-1): A gut-derived incretin hormone produced in response to food, signaling satiety to the brain and regulating insulin and gastric emptying. Dietary fiber fermentation and specific probiotic and botanical ingredients support its natural secretion from intestinal L-cells.
• Serotonin pathway: The neurotransmitter system involved in mood regulation, impulse control, and reward-seeking behavior. Declining estrogen during perimenopause reduces serotonin availability, contributing to carbohydrate cravings and mood-driven snacking.

What Supplements Cannot Address

Sleep disruption from night sweats raises ghrelin regardless of supplementation. Managing vasomotor symptoms, whether through HRT where appropriate, behavioral approaches, or other medical interventions, addresses the sleep component of perimenopause hunger more effectively than any craving supplement.

Inadequate dietary protein is the most common underlying reason meals do not produce adequate satiety, and no supplement replaces the ghrelin suppression that adequate protein at each meal produces.

WONDERBIOTICS for Perimenopause Cravings Support

WONDERBIOTICS was formulated to address several of the perimenopause craving mechanisms described above simultaneously, without stimulants.

CraveLock™ and Eriomin® (lemon extract): the formula's appetite management mechanism, based on ingredient-level clinical research on natural GLP-1 secretion support. Supports satiety hormone signaling through the gut pathway.

5X Dihydroberberine: the formula's blood sugar stability ingredient, addressing the insulin resistance component of perimenopause reactive hunger. The enhanced bioavailability form of berberine's metabolic mechanism.

B420™ (Bifidobacterium animalis subsp. lactis 420): gut-metabolic probiotic with ingredient-level RCT evidence on energy intake reduction and body fat management in overweight adults. Ingredient-level evidence; not perimenopause-specific; not a finished-product claim. CFU guaranteed at expiration.

HN019 (Bifidobacterium animalis subsp. lactis HN019): gut comfort and regularity support during perimenopause.

WONDERBIOTICS uses PolarSeal Technology to protect the probiotic blend. In testing, 99.9% of the bacterial strain survived gut-like acidic conditions and 98.2% remained alive through the point of consumption. CFU is guaranteed at expiration. The formula contains no stimulants.

The formula supports satiety, cravings management, gut comfort, and metabolic wellness during perimenopause as a non-hormonal, non-stimulant supplement. It does not replace adequate protein, dietary fiber, or sleep quality.

Read the WONDERBIOTICS Review for a full look at the formula.

This article is for educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. If you are experiencing perimenopausal symptoms or take medications, talk with a licensed clinician before starting supplements.

References

1. Gout B, Bourges C, Paineau-Dubreuil S. Satiereal, a Crocus sativus L extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women. Nutr Res. 2010;30(5):305-313. https://pubmed.ncbi.nlm.nih.gov/20579522/
2. National Institutes of Health, Office of Dietary Supplements. Dietary Supplements for Weight Loss: Health Professional Fact Sheet. Updated 2024. https://ods.od.nih.gov/factsheets/WeightLoss-HealthProfessional/
3. Stenman LK, Lehtinen MJ, Meland N, et al. Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial. EBioMedicine. 2016;13:190-200. https://pubmed.ncbi.nlm.nih.gov/27810310/